MYDEKLA 60 mg is a prescription antiviral medication containing Daclatasvir (60 mg) , used to treat chronic hepatitis C virus (HCV) infection in adults. It should be taken in the dose and duration as advised by the doctor . it should be taken with or without food , preferably at a fixed time. This medicine is part of the class of medicines known as HCV NS5A inhibitors. Before one start taking this medicine, it is essential to discuss the current health status with one doctor including any ongoing medications or pre-existing conditions . if one experience side effects while one experience side effects while on this medication , ensure to inform their doctor promptly. It is crucial to continue taking this medicine for the full duration prescribed by the doctor for the optimal results.
WHAT IS MYDEKLA 60 MG?
MYDELKA 60 mg tablets are classified as antiviral medications and specifically as HEPATITIS C virus.
Key classification :
- Pharmacological class: Direct-acting antiviral (DAA)
- Specific sub-class: Hepatitis C virus NS5A (non-structural protein 5 A) inhibitor
- Active ingredient : Daclatasvir
- Prescription status: prescription –only medicine
- Role of direct-acting antiviral therapy: MYDEKLA 60 mg is never used alone. It is always prescribed in a combination regime with other antiviral agents and is primarily indicated for treating adults with chronic HCV genotype 1 or genotype 3 infections. The goal of treatment is to prevent progressive liver scarring and lower the risk of liver failure.
WHAT ARE THE USES OF MYDEKLA 60MG?
Uses of MYDEKLA 60 MG are:
A)Treatment of chronic hepatitis C virus (HCV) infection
MYDELKA 60 mg tablet contains daclatasvir and is used with other antiviral drugs like sofosbuvir to treat chronic hepatitis C virus (HCV) infection in adults. It belongs to a group of medicines called NS5A inhibitors. It stops the hepatitis C virus from making copies of itself in the liver . it also lowers the amount of virus in the body and helps the immune system control the infection.
B)Used in combination with other antiviral medicines
MYDELKA 60 mg tablet contains daclatasvir and is used in combination with other antiviral medicines such as sofosbuvir, to treat chronic hepatitis C virus (HCV) infection in adults. One must always take MYDELKA with other anti-HCV drugs . the standard adult dose is 60 mg taken orally once daily with or without food. Treatment must be started and monitored by a doctor who knows how to manage chronic hepatitis C .
C)Considerations based on HCV genotype and patient factors
MYDELKA 60 mg is a pan-genotypic NS5A inhibitor , meaning it has antiviral across meaning it has antiviral activity across multiple strains, but it is primarily utilized for specific genotypes depending on regional guidance:
Consideration based on HCV Genotype
- Genotype1 (1a and 1b) : Highly responsive. It is typically paired with sofosbuvir for 12 weeks in patients without advanced liver disease.
- Genotype 3 : historically one of the more difficult genotypes to treat . It requires careful evaluation of liver fibrosis . patients without cirrhosis respond well to a 12-week regimen, while those with cirrhosis often require an extended duration or the addition of ribavirin.
- Genotypes 2 and 4: can also be treated with this combination under specific expert guidance , with durations ranging from 12 to 24 weeks depending on the presence of liver scarring.
Consideration based on patient factors
- Cirrhosis status: The presence and severity of liver cirrhosis significantly dictate how MYDELKA is prescribed :
- A)No cirrhosis or compensated cirrhosis : Generally treated with MYDEKLA 60 mg plus sofosbuvir for 12 weeks
- B)Decompenstated cirrohis : the liver is severely compromised . these patients require the addition of ribavirin to the MYDEKLA + sofosbuvir regime for 12 to 24 weeks to maximize the chances of a cure.
HOW MYDEKLA 60 MG WORKS?
MYDEKLA 60 mg works by blocking a vital viral protein called NS5A, which stops the hepatitis C virus from multiplying and spreading through the body. It works by the following ways:
1)Mechanism of action of Daclatasvir
DACLASTASVIR is a direct-acting antiviral medication that stops the hepatitis C virus (HCV) from multiplying by binding to and inhibiting the viral non-structural protein 5A (NS5A) . the medication stop the virus from forming new particles and breaks down the internal structures that the virus used to build copies of itself inside liver cells.
2)Inhibition of HCV NS5A protein
The NS5A protein is an essential ,multi-functional component that the virus relies on to survive and multiply. By introducing 60 mg of MYDEKLA daily, the medication disrupts the viral lifecycle through a dual –action mechanism . beyond stalling replication, it stops the virus from packaging and assembling new viral particles. This creates inactive assembly platforms and prevents the virus from spreading to healthy cells.
3)Interference with viral replication
MYDEKLA 60 mg interferes with viral replication by blocking the NS5A protein, which the hepatitis C virus (HCV) needs to make copy of itself. The medicine attaches to the non-structural protein 5 A (NS5A), stopping its normal work in the viral replication complex.
4)Role in reducing HCV viral load
MYDEKLA 60mg reduces the HCV viral load by blocking a vital viral protein called NS5A to stop the virus from multiplying in the body. The Hepatitis C virus need a specific protein named non-structural protein 5A to copy itself. MYDELKA binds to and blocks this protein. By blocking NS5A, the medicine prevents the virus from creating new copies or building new viral RNA . without the abililty to multiply, the amount of virus in the blood drops rapidly over time. Consistent use helps clear the virus from the bloodstream and protects the liver from further damage .
CONCLUSION
MYDELKA 60 mg is an antiviral medicine containing daclastasvir that must always be taken with other drugs to succefully treat chronic hepatitis C virus infection. It blocks the hepatitis C virus from copying itself inside the body, this lowers the amount of virus in the blood and protects the liver. It should be taken as prescribed by a Healthcare provider . it is neverbe used by itself.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION: WHAT IS MYDEKLA 60 MG USED FOR?
Mydekla 60 mg is an antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults. It blocks a specific viral protein to stop the hepatitis C virus in the body and helps clear the infection from the blood.
QUESTION: HOW DOES DACLATASVIR WORK?
DACLATASVIR is a direct acting antiviral medication which stops NS5A protein, which stops the hepatitis C virus from multiplying in the body. It ataches directly to a specific part of the hepatitis C virus protein called NS5A. it changes the shape of a protein and breaks down these structures, beyond blocking replication, the drug prevents new viral particle from coming together and spreading to the other healthy cells.
REFRENCES:
1)https://www.1mg.com/drugs/mydekla-60-tablet-343746?wpsrc=Google+Organic+Search
2)https://oncohealthmart.com/product-details/440/mydekla-60mg-tablet/
